This site is intended for healthcare professionals only
LoginRegister
Senores Pharma: Manohar Lalge, President- RnD, categorised as Senior Management PersonnelSenores Pharma: Manohar Lalge, President- RnD, categorised as Senior Management Personnel
Divis Labs Faces Rs 570 Crore Tax Adjustment Proposal in Draft IT Order, Plans AppealDivi's Labs elevates Nimmagadda Venkata Anirudh as President (Nutraceuticals)
USFDA Approves Corcept Therapeutics Ovarian Cancer Drug LifyorliAlembic Pharma bags USFDA nod for blood cancer drug Dasatinib
Alembic Launches First Branded Drug Pivya in US for UTI TreatmentAlembic Pharma converts UAE branch office into wholly owned subsidiary
NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, DetailsNPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin,...
Sun Pharmas ILUMYA Gets USFDA Review Nod for Psoriatic Arthritis IndicationSun Pharma open to enhance manufacturing footprint in US
Dr ReddyDr. Reddy's Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment
PCI Scraps Exit Exam Mandate for D.Pharm 2022-23, Orders States to Issue Registration CertificatesSeveral Pharmacy Colleges in Maha Cut Short DPharm Course to 5 Months Amid PCI Approval Delays
Aurobindo Pharma Q3 Net Profit Rises 8% to Rs 910 CrQ2 results: Aurobindo Pharma net profit rises 4 percent to Rs 848 crore
Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on DeleveragingSolara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on...
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsSenores Pharma arm facility gets USFDA EIR
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma net profit up 3 percent at Rs 3118 crore in Q2
X